8133 related articles for article (PubMed ID: 18283332)
21. Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach.
Zeisberger SM; Odermatt B; Marty C; Zehnder-Fjällman AH; Ballmer-Hofer K; Schwendener RA
Br J Cancer; 2006 Aug; 95(3):272-81. PubMed ID: 16832418
[TBL] [Abstract][Full Text] [Related]
22. Liposomal encapsulation enhances the antitumour efficacy of the vascular disrupting agent ZD6126 in murine B16.F10 melanoma.
Fens MH; Hill KJ; Issa J; Ashton SE; Westwood FR; Blakey DC; Storm G; Ryan AJ; Schiffelers RM
Br J Cancer; 2008 Oct; 99(8):1256-64. PubMed ID: 18797467
[TBL] [Abstract][Full Text] [Related]
23. Antitumor efficacy of dexamethasone-loaded core-crosslinked polymeric micelles.
Coimbra M; Rijcken CJ; Stigter M; Hennink WE; Storm G; Schiffelers RM
J Control Release; 2012 Nov; 163(3):361-7. PubMed ID: 23041274
[TBL] [Abstract][Full Text] [Related]
24. M1-like macrophages change tumor blood vessels and microenvironment in murine melanoma.
Jarosz-Biej M; Kamińska N; Matuszczak S; Cichoń T; Pamuła-Piłat J; Czapla J; Smolarczyk R; Skwarzyńska D; Kulik K; Szala S
PLoS One; 2018; 13(1):e0191012. PubMed ID: 29320562
[TBL] [Abstract][Full Text] [Related]
25. Targeting tumor-associated macrophages and inhibition of MCP-1 reduce angiogenesis and tumor growth in a human melanoma xenograft.
Gazzaniga S; Bravo AI; Guglielmotti A; van Rooijen N; Maschi F; Vecchi A; Mantovani A; Mordoh J; Wainstok R
J Invest Dermatol; 2007 Aug; 127(8):2031-41. PubMed ID: 17460736
[TBL] [Abstract][Full Text] [Related]
26. A TCM formula comprising Sophorae Flos and Lonicerae Japonicae Flos alters compositions of immune cells and molecules of the STAT3 pathway in melanoma microenvironment.
Liu YX; Bai JX; Li T; Fu XQ; Guo H; Zhu PL; Chan YC; Chou JY; Yin CL; Li JK; Wang YP; Chen YJ; Yu ZL
Pharmacol Res; 2019 Apr; 142():115-126. PubMed ID: 30797070
[TBL] [Abstract][Full Text] [Related]
27. The availability of drug by liposomal drug delivery : Individual kinetics and tissue distribution of encapsulated and released drug in mice after administration of PEGylated liposomal prednisolone phosphate.
Smits EAW; Soetekouw JA; Pieters EHE; Smits CJP; de Wijs-Rot N; Vromans H
Invest New Drugs; 2019 Oct; 37(5):890-901. PubMed ID: 30547315
[TBL] [Abstract][Full Text] [Related]
28. Optimization of prednisolone-loaded long-circulating liposomes via application of Quality by Design (QbD) approach.
Sylvester B; Porfire A; Muntean DM; Vlase L; Lupuţ L; Licarete E; Sesarman A; Alupei MC; Banciu M; Achim M; Tomuţă I
J Liposome Res; 2018 Mar; 28(1):49-61. PubMed ID: 27788618
[TBL] [Abstract][Full Text] [Related]
29. SKLB-M8 induces apoptosis through the AKT/mTOR signaling pathway in melanoma models and inhibits angiogenesis with decrease of ERK1/2 phosphorylation.
Wang J; Yang Z; Wen J; Ma F; Wang F; Yu K; Tang M; Wu W; Dong Y; Cheng X; Nie C; Chen L
J Pharmacol Sci; 2014; 126(3):198-207. PubMed ID: 25341684
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of antitumor effect of zoledronic acid entrapped in folate-linked liposome for targeting to tumor-associated macrophages.
Hattori Y; Yamashita J; Sakaida C; Kawano K; Yonemochi E
J Liposome Res; 2015; 25(2):131-40. PubMed ID: 25203609
[TBL] [Abstract][Full Text] [Related]
31. Targeting the pro-angiogenic forms of VEGF or inhibiting their expression as anti-cancer strategies.
Guyot M; Hilmi C; Ambrosetti D; Merlano M; Lo Nigro C; Durivault J; Grépin R; Pagès G
Oncotarget; 2017 Feb; 8(6):9174-9188. PubMed ID: 27999187
[TBL] [Abstract][Full Text] [Related]
32. The antitumour activities induced by pegylated liposomal cytochalasin D in murine models.
Huang FY; Mei WL; Li YN; Tan GH; Dai HF; Guo JL; Wang H; Huang YH; Zhao HG; Zhou SL; Li L; Lin YY
Eur J Cancer; 2012 Sep; 48(14):2260-9. PubMed ID: 22257793
[TBL] [Abstract][Full Text] [Related]
33. Oligoesculin fraction induces anti-tumor effects and promotes immune responses on B16-F10 mice melanoma.
Mokdad Bzeouich I; Mustapha N; Sassi A; Ghedira K; Ghoul M; Chebil L; Luis J; Chekir-Ghedira L
Tumour Biol; 2016 Aug; 37(8):11349-58. PubMed ID: 26960691
[TBL] [Abstract][Full Text] [Related]
34. Pharmacological macrophage inhibition decreases metastasis formation in a genetic model of pancreatic cancer.
Griesmann H; Drexel C; Milosevic N; Sipos B; Rosendahl J; Gress TM; Michl P
Gut; 2017 Jul; 66(7):1278-1285. PubMed ID: 27013602
[TBL] [Abstract][Full Text] [Related]
35. Diosmetin inhibits tumor development and block tumor angiogenesis in skin cancer.
Choi J; Lee DH; Park SY; Seol JW
Biomed Pharmacother; 2019 Sep; 117():109091. PubMed ID: 31228803
[TBL] [Abstract][Full Text] [Related]
36. Active Tumor-Targeting Nano-formulations Containing Simvastatin and Doxorubicin Inhibit Melanoma Growth and Angiogenesis.
Negrea G; Rauca VF; Meszaros MS; Patras L; Luput L; Licarete E; Toma VA; Porfire A; Muntean D; Sesarman A; Banciu M
Front Pharmacol; 2022; 13():870347. PubMed ID: 35450036
[TBL] [Abstract][Full Text] [Related]
37. Multi-parametric assessment of the anti-angiogenic effects of liposomal glucocorticoids.
Kluza E; Heisen M; Schmid S; van der Schaft DW; Schiffelers RM; Storm G; ter Haar Romeny BM; Strijkers GJ; Nicolay K
Angiogenesis; 2011 May; 14(2):143-53. PubMed ID: 21225337
[TBL] [Abstract][Full Text] [Related]
38. Characterization of a B16-F10 melanoma model locally implanted into the ear pinnae of C57BL/6 mice.
Potez M; Trappetti V; Bouchet A; Fernandez-Palomo C; Güç E; Kilarski WW; Hlushchuk R; Laissue J; Djonov V
PLoS One; 2018; 13(11):e0206693. PubMed ID: 30395629
[TBL] [Abstract][Full Text] [Related]
39. Combined MEK inhibition and tumor-associated macrophages depletion suppresses tumor growth in a triple-negative breast cancer mouse model.
Zhang Q; Le K; Xu M; Zhou J; Xiao Y; Yang W; Jiang Y; Xi Z; Huang T
Int Immunopharmacol; 2019 Nov; 76():105864. PubMed ID: 31480004
[TBL] [Abstract][Full Text] [Related]
40. Anti-angiogenic and anti-inflammatory effects of long-circulating liposomes co-encapsulating curcumin and doxorubicin on C26 murine colon cancer cells.
Sesarman A; Tefas L; Sylvester B; Licarete E; Rauca V; Luput L; Patras L; Banciu M; Porfire A
Pharmacol Rep; 2018 Apr; 70(2):331-339. PubMed ID: 29477042
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
